Federal award
ALCYONE THERAPEUTICS INC
80NSSC22K0023
Assistance
Obligated and Ceiling
- Obligated (net)
- $1,265,998.00
- Potential value
- —
- Current value
- —
- Gross positive obligations
- $1,265,998.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ALCYONE THERAPEUTICS INC · H5XUM7B92JC7
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- —
- Awarding agency
- NASA · sub-agency 8000 · office 80NSSC
- Funding agency
- NASA · sub-agency 8000
- Assistance listing (CFDA)
- CFDA 43.003
- FAIN
- 80NSSC22K0023
- Award type code
- 04
- Actions
- 17 · Dec 8, 2021 to Mar 18, 2025
- Why it is listed
- a program on the reviewed research-assistance allowlist (DoD, DOE or NASA from $10k, or eligible DHS research)
Action History17
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Mar 18, 2025 | FY2025 | P00016 | B1 | $65,998.00 | — |
| Nov 20, 2024 | FY2025 | P00015 | B1 | $50,000.00 | — |
| Sep 17, 2024 | FY2024 | P00014 | B1 | $150,000.00 | — |
| May 28, 2024 | FY2024 | P00013 | B1 | $100,000.00 | — |
| Mar 22, 2024 | FY2024 | P00012 | B1 | $0.00 | — |
| Feb 13, 2024 | FY2024 | P00011 | B1 | $125,000.00 | — |
| Dec 26, 2023 | FY2024 | P00010 | B1 | $60,000.00 | — |
| Nov 16, 2023 | FY2024 | P00009 | B1 | $60,000.00 | — |
| Sep 14, 2023 | FY2023 | P00008 | B1 | $150,000.00 | — |
| Jun 9, 2023 | FY2023 | P00007 | B1 | $100,000.00 | — |
| Apr 26, 2023 | FY2023 | P00006 | B1 | $175,000.00 | — |
| Sep 14, 2022 | FY2022 | P00005 | B1 | $25,000.00 | — |
| Aug 11, 2022 | FY2022 | P00004 | B1 | $105,000.00 | — |
| May 9, 2022 | FY2022 | P00003 | B1 | $30,000.00 | — |
| Apr 13, 2022 | FY2022 | P00002 | B1 | $20,000.00 | — |
| Jan 5, 2022 | FY2022 | P00001 | B1 | $0.00 | — |
| Dec 8, 2021 | FY2022 | 0 | A1 | $50,000.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.